268
Participants
Start Date
December 23, 2020
Primary Completion Date
January 25, 2024
Study Completion Date
October 31, 2026
Tacrolimus Pill
Envarsus® tablets dosed to achieve and maintain whole blood trough levels of tacrolimus within a patient-specific therapeutic range (interval of 3 ng/ml) that lies within a wider reference range of 3-12 ng/ml.
Tacrolimus capsule
Advagraf® capsules dosed to achieve and maintain whole blood trough levels of tacrolimus within a patient-specific therapeutic range (interval of 3 ng/ml) that lies within a wider reference range of 3-12 ng/ml.
Charite - University Medicine Berlin, Berlin
University Hospital Hamburg Eppendorf, Hamburg
University Hospital Schleswig-Holstein - Campus Kiel, Kiel
Hannover Medical School, Hanover
University Hospital Magdeburg, Magdeburg
University Hospital Essen, Essen
University Hospital Muenster, Münster
University Hospital Aachen, Aachen
University Hospital Mainz, Mainz
University Hospital Frankfurt, Frankfurt
University Hospital Heidelberg, Heidelberg
University Hospital Tuebingen, Tübingen
University Hospital Regensburg, Regensburg
University Hospital Jena, Jena
University Hospital Leipzig, Leipzig
Collaborators (2)
Chiesi Pharmaceuticals GmbH
INDUSTRY
Excelya
INDUSTRY
Edward Geissler
OTHER